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ABSTRACT To determine whether or not large macromolecules and viruses can diffuse through mucus, we observed the
motion of proteins, microspheres, and viruses in fresh samples of human cervical mucus using fluorescent recovery after
photobleaching and multiple image photography. Two capsid virus-like particles, human papilloma virus (55 nm, 20,000
kDa) and Norwalk virus (38 nm,10,000 kDa), as well as most of the globular proteins tested (15–650 kDa) diffused as rapidly
in mucus as in saline. Electron microscopy of cervical mucus confirmed that the mesh spacing between mucin fibers is large
enough (20–200 nm) for small viruses to diffuse essentially unhindered through mucus. In contrast, herpes simplex virus (180
nm) colocalized with strands of thick mucus, suggesting that herpes simplex virus, unlike the capsid virus particles, makes
low-affinity bonds with mucins. Polystyrene microspheres (59–1000 nm) bound more tightly to mucins, bundling them into
thick cables. Although immunoglobulins are too small to be slowed by the mesh spacing between mucins, diffusion by IgM
was slowed by mucus. Diffusion by IgM-Fc5, the Fc pentamer core of an IgM with all 10 Fab moieties removed, was
comparably slowed by mucus. This suggests that the Fc moieties of antibodies make low-affinity bonds with mucins.
INTRODUCTION
Mucus that coats the surfaces of the gastrointestinal, respi-
ratory, and reproductive tracts provides the outermost bar-
rier against pathogens. Secreted mucins, the gel-forming
component of mucus, are large proteins (10–40 MDa, 0.5–5
m long) that are highly glycosylated (up to 80% sugar by
weight) and that form an entangled viscoelastic gel (Carl-
stedt and Sheehan, 1989; Cone, 1999; Forstner et al., 1995;
Nieuw Amerongen et al., 1998).
Early work indicated that mucus slows the diffusion of
small molecules and protons (Allen, 1978, 1981; Desai et
al., 1992; Desai and Vadgama, 1991; Williams and Turn-
berg, 1980; Winne and Verheyen, 1990). This led to the
belief that large proteins would not penetrate mucus gels.
These early experiments measured the diffusional flux of
particles between two stirred chambers through a layer of
mucus sandwiched between filters. Ostensibly straightfor-
ward, this method is subject to major artifacts (Sanders et
al., 2000), including an inability to control, or adequately
account for, the unstirred layer of fluid adherent to the outer
surfaces of the filters. Moreover, mucus is very sticky and
can clog filters, reducing the apparent diffusion coefficient.
Over the past several years, two techniques have been
developed for directly measuring diffusion of molecules in
fresh samples of mucus subjected to minimal dilution and
handling: fluorescent recovery after photobleaching (FRAP)
and fluorescent imaging of profiles. In these methods, the
diffusion of fluorescently labeled particles can be observed
without the use of filters or need for stirring. These methods
have shown that many proteins (1.2–150 kDa), including
immunoglobulin (IgG), diffuse in mucus nearly as fast as
they diffuse in water, indicating that the mesh spacing
between fibers of mucins must be large enough not slow
their diffusion (Henry et al., 1992; Radomsky et al., 1990;
Saltzman et al., 1994; Zeitlin et al., 1998).
Few studies have looked at diffusion of larger particles in
mucus. In vivo experiments have explored uptake of micro-
spheres in the gastrointestinal tract of rats. Small polysty-
rene microspheres (14 and 415 nm) placed in the distal
colon of rats, were later observed adjacent to the mucosa
whereas larger microspheres (1.1 m) remained in the lu-
men and in the mucus layer of the colon (Szentkuti, 1997).
Others have reported that microspheres (50 nm, 500 nm,
and 1 m) fed orally to rats were taken up by Peyer patches
in the gastrointestinal tract, but also showed that micro-
spheres were trapped by the mucus layer around the Peyer
patches (Jani et al., 1992). However, these studies were not
able to differentiate between microspheres diffusing
through mucus and microspheres being transported or mov-
ing because of peristaltic stirring. With this in mind, one
aim of the present study was to determine whether proteins
larger than IgG (150 kDa), and even viruses, can diffuse in
mucus.
Using FRAP and fluorescent imaging of profiles, Saltz-
man et al. (1994) reported that Igs can diffuse rapidly
through mucus, although not as rapidly as in saline. Their
results did not clarify whether the Igs were slowed by the
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mesh spacing between mucin fibers, or whether antibodies
bind with low affinity to mucins. Kremer and Jager (1976)
found that antisperm antibodies, including IgG, IgA, and
IgM, were found to be capable of cross-linking motile
sperm to the mucus gel, causing the sperm to shake in place.
This “shaking phenomenon” clearly suggested that antibod-
ies bound to sperm cross-link the sperm to the mucus gel,
trapping the sperm in the gel by forming multiple low-
affinity bonds with the mucin fibers. Thus, another aim of
this study was to determine whether antibodies are retarded
by the mesh spacing and/or by low-affinity bonds with
mucins. Also, we sought to determine which antibody moi-
ety forms low-affinity bonds with mucins.
That large proteins are small enough to diffuse unhin-
dered by the mucin fiber mesh spacing was suggested by
previous electron microscopy (EM) of mucus gels. Early
electron micrographs of mucus indicated that the mesh
spacing was 90–3000 nm (Chretien et al., 1975; Poon and
McCoshen, 1985; Yudin et al., 1989), much larger than the
hydrodynamic diameter of most globular proteins (2–15
nm). But these same micrographs indicated that the diam-
eter of the mucin fibers was 50 nm, much too large to be
consistent with the biochemical structure of mucin fibers, or
the thickness of individual mucin fibers as observed by EM
and by atomic force microscopy (AFM). Biochemical anal-
ysis (Yurewicz et al., 1987) of the sugars attached to mucins
predicts, and EM (Slayter et al., 1991) and AFM (McMaster
et al., 1999) of purified individual mucins adhering to a
substrate surface all indicate that the diameter of mucin
fibers is 3–10 nm. Thus, the much larger fibers observed in
earlier EM of mucus gels was probably because of fibers of
mucins becoming bundled together during the preparative
and fixation process. Such bundling, or cabling, of mucin
fibers not only artifactually increases the apparent fiber
diameter, it also artifactually increases the apparent mesh
spacing between mucin fibers. Therefore, the final aim of
this study was to obtain transmission electron micrographs
of human cervical mucus (HCM) gels by a novel fixation
method that seems to minimize artifactual thickening of
mucin fibers and, hence, more likely reveals the actual mesh
spacing.
MATERIALS AND METHODS
Mucus collection
HCM samples were collected using procedures approved by the Review
Board on the Use of Human Subjects at the Johns Hopkins University and
UC-Davis School of Medicine. Women not on hormonal contraceptives
monitored their hormonal cycle to determine their time of ovulation.
Cervical mucus at the time of ovulation, or midcycle, has lower viscosity
and is produced in greater volume than the mucus produced during the rest
of the cycle, and is therefore more easily sampled. At midcycle, women
came to the health center and their mucus was collected from the cervix
with a sterile 1-cc syringe (no needle). Samples were immediately deliv-
ered to the laboratory where they were stored at 4°C until used.
Only those samples that met criteria outlined by the World Health
Organization for sperm-cervical mucus interaction were used (WHO,
1992). The samples were weighed, clarity was observed visually, and pH
was measured using a glass microelectrode (MI-414–6 cm, Microelec-
trodes, Inc., Bedford, NH). Spinnbarkeit was measured by placing a small
sample of mucus on a glass slide. Then a wooden cytology spatula (Baxter
Healthcare Corp., McGaw Park, IL) was pressed against the sample and
slowly lifted vertically. Spinnbarkeit is the length at which the mucus
thread breaks. Samples accepted for further analysis were 0.2 ml in
volume, free of cellular debris, in the pH range 6.4–8.0, and had spinn-
barkeit 5 cm. Samples were used within one week of receiving them.
Fluorescently labeled proteins, viruses,
and microspheres
Fluorescein isothiocyanate (FITC, Molecular Probes, Eugene, OR)-labeled
purified human IgA, IgG, IgM, IgM-Fab (the Fab fragment of an IgM),
IgM-Fc5 (the Fc pentamer core of an IgM), and aggregated secretory IgA
(sIgA) were purchased from Jackson ImmunoResearch Labs (West Grove,
PA). Cationized ferritin-tetra methylrhodamine (TMR) and ferritin-TMR
were purchased from Molecular Probes. Cholera toxin B subunit, -amy-
lase, human lactoferrin, chicken lysozyme, human lysozyme, myoglobin,
and pepsin were all purchased from Sigma (St. Louis, MO). Proteins that
were not already fluorescently labeled were labeled with FITC according to
the manufacturer’s instructions. Fluorescently labeled microspheres were
purchased from Polysciences, Inc (Warrington, PA).
Human papilloma virus-like particles (VLPs) were a gift from Dr. John
Schiller at the National Cancer Institute and Dr. Richard Roden at the Johns
Hopkins School of Medicine. Norwalk VLPs were a gift from Dr. Mary
Estes at the Baylor College of Medicine. VLPs were labeled with any of
these four fluorophores: FITC, 5-iodoacetamidofluorescein, tetramethyl-
rhodamine-5-(and-6)-isothiocyanate (Molecular Probes) and iodoacet-
amido tetramethylrhodamine (Research Organics, Inc, Cleveland, OH).
VLPs were labeled in 10 mM phosphate-buffered saline (PBS, Sigma) with
0.02% sodium azide at 50 g label/mg of VLP. The reaction was allowed
to proceed at 4°C for 3 h before being quenched with excess glycine
(Sigma). The mixture was sonicated (bath sonicator, Branson B-220,
VWR, West Chester, PA) five times at 4°C for 15 s with a 15-s rest
between each pulse. Free dye was removed by chromatography on either
Sepharose CL-2B (0.7  48 cm, Amershan Pharmacia Biotech, Piscat-
away, NJ) or 10DG (10 ml desalting column, Bio-Rad, Hercules, CA).
Herpes simplex virus 1 (HSV) with green fluorescent protein attached
to the capsid protein L2 (Desai and Person, 1998) was a gift from Dr.
Prashant Desai at the Johns Hopkins School of Medicine.
Diffusion measurements
Two methods were used to measure diffusion of probes in mucus. FRAP
has been described previously (Axelrod et al., 1976; Wolf, 1989). An
attenuated laser beam is focused through a modified epifluorescent micro-
scope to a small point (4 m in diameter) in a sample (mucus, saline,
water, etc.) containing the fluorescent probe of interest (HPV, antibodies,
etc.). The attenuator is transiently removed to increase the intensity of the
beam approximately 103- to 104-fold, which rapidly and irreversibly
bleaches a fraction (typically 20–50%) of the fluorescent molecules in this
part of the sample. After a bleach exposure lasting 10–40 s, the attenu-
ator is replaced in the laser beam and the residual fluorescence from the
same area in the sample is monitored. As unbleached probes diffuse into
the partially bleached area, the fluorescent signal returns to a new steady-
state value. The rate at which the fluorescence recovers reveals the rate of
diffusion of the fluorescent particles. Also, the fractional recovery of the
fluorescent signal corresponds to the fraction of the fluorescent probes that
are mobile.
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In mucus samples with fluorescently labeled HSV, the fluorescent
signal was not sufficiently uniform or sufficiently bright to perform useful
FRAP experiments. In these cases, diffusion was observed with multiple
image photography (MIP) of individual fluorescent particles. Using an
epifluorescent microscope (600, Nikon E-800, Tokyo, Japan), images of
individual fluorescently labeled HSV in samples of mucus and saline were
recorded with a charge-coupled device camera (Princeton Instruments Inc.,
Trenton, NJ). Two images of the same field were taken 1.5–50 s apart.
IPLab Spectrum (Signal Analytics Corp., Fairfax, VA) was used to analyze
the images. Successive images were subtracted from one another to reveal
the particle displacements, ‚r, that occurred between images. The diffu-
sion coefficient was calculated using the equation: D  ‚r2/4‚t. This
system was validated by measuring diffusion coefficients for fluorescent
latex microspheres of well defined diameter in PBS.
Samples were prepared similarly for both FRAP and MIP. Aliquots of
proteins or VLPs were sonicated for 15 s three times to minimize aggre-
gation (20% power, duty cycle 2, 15 s rest between each sonication,
Branson Sonifier, VWR). Aliquots of cervical mucus (0.01–0.04 g) were
measured on a balance. A 1:10 (v/w) dilution of 20 mg/ml bovine serum
albumin (Sigma) was added to samples that did not already contain bovine
serum albumin and stirred to help prevent fluorescently labeled probes
from sticking to the glass. Finally, the fluorescent probe was added (1:10
v/w dilution) and stirred by hand with a glass rod at least 50 times. This
method diluted the mucus no more than 20%, and because the average
mesh spacing between mucin fibers varies inversely with the square root of
mucin concentration, this 20% dilution probably increased the average
mesh spacing by10%. For FRAP samples, the mucus was then drawn by
suction into a flat capillary tube (microslides, 0.3  3.0 mm ID, VitroCom
Inc., Mt. Lakes, NJ) which was sealed with Critoseal (VWR). For MIP
samples, the mucus was placed on a microscope slide to which a small
piece of double-sided tape (3M, St. Paul, MN) that had a 1 cm  1 cm
square cutout was applied. This sample area was then sealed with a
coverslip. The double-sided tape ensured that the sample was not com-
pressed excessively. The capillary tubes, microscope slides, and coverslips
were all pretreated with silicon (Rain-X, Unelko Corp., Scottsdale, AZ) to
minimize sticking of the labeled probes to the glass.
EM
Fresh HCM samples were drawn into sterile catheters (Infant Feeding
Tube, 8 FR  15, Mallinckrodt Baker, Glens Falls, NY) and the catheter
was then cut into 5-mm long sections. These mucus-containing sections
were immersed for 1 h in fixative (10% dimethylsulfoxide (DMSO),
Mallinckrodt Baker), 2% glutaraldehyde in 0.1 M cacodylate (Electron
Microscopy Sciences (EMS), Fort Washington, PA)). The mucus samples
were then placed into 100% DMSO and plunged into liquid propane that
had been cooled to 160°C with liquid nitrogen. After 30–60 s, the
samples were removed from the liquid propane and placed in 100%
methanol (Mallinckrodt Baker) precooled to 80°C. Samples were left in
100% methanol at 80°C for 4–6 days, then placed in 1% OsO4 (EMS)
in 100% methanol (precooled to 80°C). Samples were left at 80°C for
2–4 h, moved to20°C for 8 h, and then left at room temp for 1 h. Finally,
samples were washed with 100% methanol, removed from the catheters,
and embedded in epon (EMbed 812, EMS). Sections were cut with a
diamond knife (Delaware Diamond Knives, Wilmington, DE) and placed
on grids (EMS) for observation with a Phillips 410 electron microscope at
80 kV (Phillips, Amsterdam, Netherlands).
RESULTS
The results of experiments on the diffusion of macromole-
cules and viruses in human midcycle cervical mucus are
compiled in Table 1. The ratio of diffusion coefficients,
Dmuc/Dpbs, indicates the speed with which a probe diffuses
in mucus compared with saline buffer. If this ratio 1, then
the probe diffuses as rapidly in mucus as in buffer, whereas
a value 1 implies that the probe is slowed by mucus.
Most proteins (15–650 KDa) diffused as fast in mucus as
they did in water (Dmuc/Dpbs  0.84–1.1) and had  93%
recovery. Three proteins, human lysozyme, cholera toxin B
subunit, and cationized horse ferritin seemed to be slowed
slightly (Dmuc/Dpbs  0.68–0.75), but the error limits indi-
cate that these observations were not significantly 1.
However, three Ig molecules were slowed significantly
(Dmuc/Dpbs  0.24–0.51). These were IgM, IgM Fc5 (the
Fc pentamer core of an IgM molecule with all 10 Fabs
removed), and small aggregates of sIgA molecules. Based
on hydrodynamic radius inferred from Dpbs, the sIgA sam-
ples are estimated to be aggregates of 6 to 10 Ig molecules.
Not only was the diffusion of these Igs slowed, their per-
centage recovery was somewhat lower.
Surprisingly, two VLPs diffused as fast in mucus as they
did in saline. These were Norwalk VLP (38-nm diameter)
and HPV VLP (55-nm diameter). Not only did the VLPs
readily diffuse in mucus, their percentage recovery was 85%
and 76%. The diffusion coefficients measured in saline for
both VLPs matched what would be expected for particles
their size, ensuring that VLPs and not capsid monomers
were being observed. Further, when the samples were ob-
served with epifluorescence at 600 magnification, the
fluorescence was uniform throughout the mucus sample,
indicating that Norwalk and HPV did not adhere to mucus
strands nor were they excluded from areas of concentrated
mucins.
Unlike the diffuse fluorescence of HPV samples, fluores-
cently labeled polystyrene microspheres (59 nm to 1 m)
mixed into mucus stuck tightly to the mucins and collapsed
the mucus gel into thick “cables” of aggregated mucin
strands (Fig. 1). FRAP experiments showed no recovery
after bleaching, thus Dmuc  0 for microspheres, regardless
whether the microspheres were unmodified polystyrene or if
their surfaces were functionalized with carboxylate, epoxy,
or amino groups.
Similarly, visual observation of HSV in mucus showed
that HSV colocalized with mucus strands in the sample (Fig.
2). Also, HSV in mucus did not visibly move during direct
visual observations, unlike HSV in PBS, which could be
observed moving within the expected range of thermal
velocities. In some mucus samples, there were regions
where the mucus appeared thinner and HSV was more
evenly distributed. In these regions, MIP was performed. At
least eight different mucus samples were observed and
displacements for approximately 100 virions were obtained
per sample. Comparing these observations with diffusion of
HSV in PBS, the HSV in regions of thin mucus was slowed
100- to 1000-fold (Dmuc/Dpbs  (8.9 	 5.2)  103). To
ensure that the sticking or cabling of HSV in mucus was not
caused by interactions with anti-HSV antibodies, each of
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these mucus sample was tested for the presence of anti-HSV
antibodies by an immunofluorescent assay (Gallo, 1986).
None of the mucus samples used for HSV experiments
contained detectable anti-HSV antibodies by immunofluo-
rescent assay.
The mesh spacing in a typical sample of HCM fixed with
glutaraldehyde delivered in DMSO is revealed by EM (Fig.
3). Throughout the gel, the mesh spacing ranged from
20–200 nm and the individual fibers had a diameter of
5–15 nm.
DISCUSSION
Two major mechanisms may stop particles from readily
diffusing through a mucus gel. Particles can stick to mucin
fibers or they can be hindered by the size of the mesh
spacing between the mucin fibers. We studied the diffusion
of fluorescently labeled proteins, VLPs, an enveloped virus,
and polystyrene microspheres in fresh, only slightly diluted
samples of human midcycle cervical mucus. Most of the
proteins tested were able to diffuse in these samples of
mucus as fast as they diffuse in water, indicating that the
size of the mesh-spacings in these mucus samples did not
significantly hinder or block the diffusion of any proteins
tested. These results confirm earlier studies that showed
small molecules and proteins could diffuse in mucus as fast
as they diffused in water (Radomsky et al., 1990; Saltzman
et al., 1994) and expand the number of different proteins
that have been studied.
Most surprising were the results that Norwalk and HPV
VLPs, two large multimeric protein capsid assemblies, dif-
fused in mucus as fast as they diffused in saline buffer.
VLPs are virus protein capsids that contain no nucleic acid.
Their external surfaces are the same as infectious virions,
but they are safer to handle and use experimentally and can
be produced in large quantities. Norwalk VLPs are 38 nm
(Venkataram Prasad et al., 2000) and HPV VLPs are 55 nm
(Rose et al., 1993) in diameter with molecular masses of
10,000 kDa and 20,000 kDa, respectively. Thus, these
VLPs are much larger than any particles previously shown
to diffuse unhindered in mucus. In contrast, a larger envel-
oped virus, HSV (180 nm), did not readily diffuse in mucus
and also seemed to stick to and colocalize with the mucin
strands.
TABLE 1 Diffusion of proteins and viruses in human cervical mucus
Probe MW (kDa) d (nm) Dmuc/Dpbs % R N n
h lysozyme 15 3.5* 0.75 	 0.23 96 	 1 2 20
Horse myoglobin 17 3.8† 0.84 	 0.21 96 	 2 5 55
Chicken lysozyme 14 4.1† 1.1 	 0.2 96 	 4 2 21
Porcine pepsin 35 4.5† 0.98 	 0.02 96 	 1 4 32
h IgM Fab 50 6.0‡ 0.94 	 0.23 94 	 13 6 110
Cholera toxin B subunit 55 5.4* 0.68 	 0.15 102 	 2 5 60
h -amylase 59 5.5* 0.90 	 0.02 100 	 2 2 28
h lactoferrin 82 6.1* 0.86 	 0.21 101 	 6 3 28
h IgG** 152 11† 0.87 	 0.19 97 	 1 5 51
h IgG** 152 11† 1.1 	 0.1 98 	 1 5 100
h IgA** 160 11§ 0.85 	 0.02 98 	 1 2 30
h IgA** 160 11§ 1.1 	 0.2 97 	 1 4 80
h IgM Fc5 300 11§ 0.41 	 0.12 87 	 4 6 120
Horse ferritin 650 12* 0.88 	 0.18 93 	 11 4 44
Cationized horse ferritin 650 12* 0.73	 0.32 97 	 4 3 34
h IgM** 950 16§ 0.51 	 0.17 95 	 4 5 56
h IgM** 950 16§ 0.33 	 0.11 82 	 22 6 120
h sIgA aggregates 18§ 0.24 	 0.16 76 	 11 4 33
Norwalk VLP 10,000 38¶ 1.1 	 0.4 85 	 8 11 130
HPV VLP** 20,000 55 1.1 	 0.2 76 	 17 18 209
HPV VLP** 20,000 55 1.3 	 0.4 92 	 10 3 50
HSV†† 180 0.0089 	 .0052 n/a 8 768
h represents human proteins. d is the Stokes diameter (nm) for the probes.
*Calculated from the Stokes-Einstein equation (d  kT/3Dwater where k is Boltzmann’s constant, T is absolute temperature,  is the viscosity of water,
using Dwater taken from Sober, 1970.
†Calculated from the Stokes-Einstein equation where diffusion coefficients were unknown and were calculated from Dwater A(Mw)1/3 whereMw is given
by the manufacturer and A  300 cm2(Da)1/3s1 (Polson, 1950).
‡Calculated from the Stokes-Einstein using Dwater (Saltzman et al., 1994).
§Calculated using Stokes-Einstein with Dpbs using IgG as a standard.
¶EM of Norwalk VLPs (Venkataram Prasad et al., 2000).
EM of HPV VLPs (McCarthy et al., 1998). %R is the percentage fluorescent recovery. N is the number of mucus samples observed. n is the total number
of recovery curves observed for FRAP experiments and total number of virions tracked for MIP experiments.
**probes listed twice were tested by two investigators at different times and are reported separately.
††HSV results are from MIP experiments, all other probes are from FRAP experiments.
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Polystyrene microspheres 59–1000 nm in diameter, sim-
ilar in size to the virus particles, seemed to adhere even
more tightly to mucin fibers than to HSV, and formed dense
cables (Fig. 1). Even with the smallest microsphere, 59 nm,
no diffusion of microspheres was detectable with FRAP.
These observations are consistent with the observations that
microspheres orally ingested by the rat are trapped in the
mucus gel of the gastrointestinal tract (Jani et al., 1992). In
striking contrast, both HPV and Norwalk VLPs diffused
unhindered through mucus. Because these viruses are con-
structed with a large number of capsid monomers that could
potentially make highly polyvalent bonds between the virus
particle and the mucus gel, to diffuse through mucus with-
out slowing, Norwalk virus and HPV must have evolved
external capsid surfaces that do not make any bond, even
very low-affinity bonds, with mucins. Capsid monomers
might minimize affinity bonds to mucins by being densely
coated with both positive and negative charges, an adhe-
sion-preventing mechanism present on the surface of most
soluble proteins (Wada and Nakamura, 1981). In addition,
capsid viruses must have few, if any, exposed hydrophobic
regions that can make highly polyvalent bonds with the
hydrophobic domains distributed along mucin fibers (Cone,
1999).
Nonmotile mucosally transmitted pathogens must usually
diffuse to contact their target cells. These experiments sug-
gest that small capsid viruses are capable of diffusing
through the protective mucus coat to reach these target cells.
In fact, many protein capsid viruses are smaller than 55 nm,
with polio virus being 30 nm and rotavirus being the
largest at 75 nm (Fields et al., 1996). In contrast, HSV, an
enveloped virus, sticks to mucus and will therefore be
trapped by the mucus gel. Thus, HSV seems most likely to
infect cells not coated with mucus, such as cells exposed by
abrasion.
Most soluble proteins tested were not significantly
slowed in mucus. However, IgM, IgM-Fc5, and small
aggregates of sIgA were slowed 3- to 5-fold in mucus.
These Igs are significantly smaller than the Norwalk and
HPV VLPs that were not slowed in mucus. Thus, these Igs
FIGURE 1 Polystyrene microspheres in HCM. Fluorescently labeled 59
nm microspheres formed cables with mucins in the mucus gel. (A) Fluo-
rescent image. (B) Phase image. Scale bar  500 m.
FIGURE 2 Herpes simplex virus in HCM and PBS. Fluorescent images
of HSV are shown in mucus (A) and PBS (B). Note that HSV seems to
colocalize with strands of mucus, but was randomly dispersed in PBS.
Scale bar  20 m.
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must not be hindered by the mesh spacing in mucus. In-
stead, Igs seem to be slowed by making low-affinity bonds
with the mucins. That antibodies must bind to mucins has
been inferred from the shaking phenomenon, in which an-
tisperm antibodies (IgG, IgA, or IgM) that accumulate on
the sperm surface trap individual vigorously motile sperm in
mucus; such antibody-coated sperm shake in place for hours
and never swim free unless the mucus gel is highly diluted
(Jager et al., 1981; Kremer and Jager, 1976). The binding
between antibodies and mucins must have very low affinity
because the diffusion of IgG, with only one Fc region, was
not slowed significantly in mucus but the antibodies with
multiple Fcs were significantly slowed. Unlike IgG, IgM,
with 5 Fcs, and small aggregates of sIgA with 6 to 10 Fcs
are capable of forming multiple low-affinity bonds with
mucins. In fact, although there are many experimental re-
sults that indirectly indicate that mucins bind antibodies
with low affinity (Biesbrock et al., 1991; Kremer and Jager,
1976; McSweegan et al., 1987; Miller et al., 1981), several
biochemical methods have failed to detect or characterize
the low-affinity bonds that must form between antibodies
and mucus (Crowther et al., 1985; Iontcheva et al., 1997).
The results reported here indicate that it is the Fc moiety of
an antibody that binds to mucins, consistent with shaking
phenomenon experiments (Jager et al., 1981). Cleaving the
Fab molecules from an IgM leaves a pentameric ring of Fcs
joined by the IgM J-chain. The diffusion of this pentameric
Fc ring (IgM Fc5) was slowed to the same extent as the
whole IgM. If the Fab portion of antibodies made significant
affinity bonds with mucins, then removing all 10 Fabs from
an IgM would be expected to markedly increase the speed
of diffusion of the IgM Fc5. Because no change was
detected, it must be the pentameric Fc ring that makes
low-affinity bonds with mucins.
We have used a novel approach to prepare mucus for EM.
During fixation, DMSO serves as a carrier, which elevates
the penetrability of the glutaraldehyde and thereby allows
rapid diffusion of the fixative well into the gel, minimizing
artifacts of cabling and outer-surface condensation. Unlike
previous EM preparations, these images, showing fiber di-
ameters of 5–15 nm and mesh spacing of 20–200 nm, are
consistent with biochemical, AFM, and EM studies of in-
dividual mucin monomers (McMaster et al., 1999; Slayter et
al., 1991; Yurewicz et al., 1987).
Many empirical models have been developed to analyze
diffusion in polymer gels (Amsden, 1998). The model that
best fits experimental data is the obstruction-scaling model
that was developed for covalently cross-linked hydrogels
but is equally applicable to gels with physical entanglement
cross-links (Amsden, 1998, 1999). This model treats cases
in which the effective radius of the mesh spacing is greater
than the hydrodynamic radius of the diffusing particle and
assumes no interaction between the solute and the polymer
(Amsden, 1999). The model describes the ratio of diffusion
in a gel and diffusion in water as:
Dg/Do exp
/4rs	 rf/rg	 rf2
where Dg is the diffusion coefficient of the particle in the
polymer gel, Do is the diffusion coefficient of the particle in
water, rs is the radius of the particle, rf is the gel fiber radius,
and rg is the effective radius of the mesh spacing.
This model was developed for chemically cross-linked
hydrogels such as poly(ethylene oxide), poly(vinyl alcohol),
and poly(acrylamide), among others. These hydrogels have
a very small fiber radii (0.2–0.3 nm) and well character-
ized repeating chemical subunits. In contrast, mucin fibers
are 10–50 times thicker, and have markedly more chemical
variety because of their complex sugar branches inter-
spersed between stretches of relative hydrophobic peptide
sequences. However, mucins are long, linear, polymeric
chains which, although not chemically cross-linked, do
FIGURE 3 Transmission EM of
HCM. This is a typical image of fixed
HCM (80 nm thick). Note the interfi-
ber spacing varies between regions of
low and high density, but ranges from
10 s to 200 nm. Similarly, individual
fibers can be observed with fiber diame-
ters 10 nm. Scale bar  200 nm.
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form a physically entangled gel that may be further stabi-
lized by low-affinity bonds between hydrophobic domains
(Cone, 1999).
We have applied Amsden’s obstruction-scaling model to
HCM and have plotted the diffusion ratios predicted by this
model in Fig. 4. We used a mucin fiber radius (rf) of 3.5 nm
which is our best estimate from biochemical, EM, and AFM
observations of individual mucin fibers and our images of
mucus gels. We calculated the mesh spacing within a mucus
gel using a simple cubic-lattice model of cylindrical fibers.
This cubic-lattice model predicts a mesh spacing of 100 nm,
which is consistent with the values we observe in EM of
fresh HCM (Fig. 3). Because the mucus samples were
diluted 20% in the process of adding the fluorescent probes,
the radius of the average mesh fiber spacing would increase
by 10%. We plotted Amsden’s model with both 50 nm
(solid line) and 55 nm (dotted line) rg to show the limited
effect that a 10% change in mesh fiber spacing has on
diffusion in the mucus gel. Therefore, we would not expect
diffusion of proteins and viruses in vivo to differ signifi-
cantly from what we observe in these slightly diluted sam-
ples.
As indicated in Fig. 4, Amsden’s model predicts that
HPV and Norwalk would diffuse essentially unhindered in
mucus. Also, the model predicts Dmuc/Dpbs for HSV would
be reduced by 10-fold. However, because HSV colocal-
ized with mucin strands and only diffused in regions of
mucus that seemed to be thinner, our observations suggest
that HSV is slowed not only by the mesh spacing but also by
making multiple low-affinity bonds to mucin fibers.
Whereas Amsden’s model indicates a sharp cutoff for par-
ticles diffusing in a gel, only HSV fell within the sharp
cutoff range. Therefore, although our results with HPV
provide a lower limit on the mesh spacing of human mid-
cycle cervical mucus, and because HSV binds lightly to
mucin fibers, our results do not provide an upper limit on
mesh spacing.
Mucus gels have long been considered a diffusional bar-
rier for the surfaces they cover. Our data suggest, however,
that most proteins and even capsid viruses can diffuse
through mucus unhindered. In fact, mucus only trapped a
larger enveloped virus, HSV. However, because Igs seem to
make low-affinity bonds with mucins, and the rate of dif-
fusion decreases with the number of Fc moieties per diffus-
ing particle, our results suggest that when antibodies accu-
mulate on the surface of a pathogen, they may be able to
form a sufficient number of low-affinity bonds to trap
pathogens in the gel, similar to what is seen for sperm
(Kremer and Jager, 1976; Cone, 1999) as well as bacteria
(Biesbrock et al., 1991; McSweegan et al., 1987).
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